ICREBDA Trademark

Trademark Overview


On Tuesday, May 22, 2018, a trademark application was filed for ICREBDA with the United States Patent and Trademark Office. The USPTO has given the ICREBDA trademark a serial number of 87932029. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 25, 2025. This trademark is owned by Glaxo Group Limited. The ICREBDA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment o...
icrebda

General Information


Serial Number87932029
Word MarkICREBDA
Filing DateTuesday, May 22, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 25, 2025
Registration Number5654694
Registration DateTuesday, January 15, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, July 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Thursday, May 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 25, 2018NEW APPLICATION ENTERED
Wednesday, September 12, 2018ASSIGNED TO EXAMINER
Wednesday, September 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 21, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 26, 2018ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 11, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 11, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 11, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 11, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 15, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 25, 2025CANCELLED SEC. 8 (6-YR)